统一巴洛方案(UP)与神经心理治疗对癌症幸存者认知障碍的有效性:随机对照试验研究方案
该研究为三臂随机优效性临床试验,计划纳入123名轻中度认知障碍的癌症幸存者,按1:1:1随机分配至认知康复组、统一巴洛方案(UP)组或等待名单对照组。主要结局为两个干预组相较等待名单组在认知功能上的显著改善及情绪损害的显著降低,次要结局包括焦虑、抑郁与生活质量的改善,并预期在6个月随访时维持。
要点
- 三臂随机优效性试验比较认知康复、UP与等待名单对照,分配比1:1:1。
- 计划纳入123名轻中度认知障碍癌症幸存者。
- 主要结局为认知功能改善与情绪损害降低,随访至6个月。
核心结论
- 该试验旨在检验UP干预对减轻乳腺癌幸存者认知缺陷的疗效,结果可能有助于减少癌症幸存者的认知问题并改善其情绪状态与生活质量。
研究设计与样本
- 三臂、随机优效性临床试验,采用组间前后及重复随访测量设计,分配比1:1:1。
- 计划纳入123名轻中度认知障碍的癌症幸存者,随机分配至认知康复干预组、UP干预组或等待名单对照组。
主要发现
- 主要结局为观察两个干预组相较等待名单组在认知功能上的显著改善及情绪损害的显著降低。
- 次要结局预期包括焦虑、抑郁与生活质量的改善,并预期在6个月随访时维持。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cancer survivors frequently develop cognitive impairment, which negatively affects their quality of life and emotional well-being. This study compares the effectiveness of a well-established treatment (neuropsychological treatment) with the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) to reduce these cognitive deficits and evaluate the effect of both treatments on anxiety-depressive symptoms and the quality of life of cancer survivors. METHODS: A three-arm, randomized superiority clinical trial with a pre-post and repeated follow-up measures intergroup design using a 1:1:1 allocation ratio will be performed. One hundred and twenty-three cancer survivors with mild to moderate cognitive impairment will be randomly assigned to one of the study interventions: a cognitive rehabilitation intervention group, an intervention group with UP intervention, or a control group on the waiting list. The primary outcome is to observe a significant improvement in cognitive function in both intervention groups and a significant decrease in emotional impairments in comparison with the waitlist group. Improvements in anxiety, depression, and quality of life are also expected as secondary outcomes. These results will be maintained at 6 months of follow-up. DISCUSSION: The aim of this trial is to test the efficacy of the UP intervention in reducing cognitive deficits in breast cancer survivors. The results of this trial may be useful in reducing the presence of cognitive problems in cancer survivors and improving their emotional state and quality of life. TRIAL REGISTRATION: ClinicalTrials.gov NCT05289258. Registered 12 March 2022, v01.
引用
- García-Torres F, Tejero-Perea A, Gómez-Solís Á, et al. Effectiveness of the Unified Barlow Protocol (UP) and neuropsychological treatment in cancer survivors for cognitive impairments: study protocol for a randomized controlled trial. Trials. 2022. PMID: 36175973. doi:10.1186/s13063-022-06731-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。